GLP-1 Medications and Cravings: What’s the Conversation in Addiction Treatment?

I try to stay current with emerging research in mental health and addiction treatment, and I was recently struck by a discussion about GLP-1 receptor agonist medications — drugs like Ozempic, Wegovy, and Mounjaro — and their possible role in reducing cravings.

These medications were originally developed for diabetes and later became widely known for their effects on appetite and weight loss. Now researchers are exploring whether they may also affect the brain systems involved in reward, motivation, and craving — areas that are central to addiction.

This is still an evolving area of research, but it raises interesting questions about how biology and behavior interact in recovery.

A Quick Look at Medications Already Used in Addiction Treatment

Medication support in addiction treatment is not new. Several medications have long been used alongside therapy and recovery programs:

• Naltrexone is used for alcohol and opioid use disorders and can reduce the rewarding effects of substances.

• Acamprosate helps stabilize brain chemistry after alcohol cessation.

• Disulfiram (Antabuse) creates an unpleasant reaction if alcohol is consumed.

• Buprenorphine and methadone are widely used in the treatment of opioid use disorder to reduce withdrawal and cravings.

  
  

These medications don’t replace therapy or recovery work, but they can reduce the intensity of cravings, making behavioral change more achievable.

What Are GLP-1 Medications?

GLP-1 receptor agonists are medications that mimic a naturally occurring hormone involved in regulating blood sugar, appetite, and digestion. They increase feelings of fullness and reduce hunger, which is why they’ve been so widely used in diabetes and weight management.

Researchers are now studying whether these medications also affect the brain’s reward pathways — the same systems involved in substance use and compulsive behaviors.

Why Are Researchers Interested in GLP-1s for Cravings?

Early findings and anecdotal reports suggest that some people taking GLP-1 medications notice a reduced urge to drink alcohol, smoke, or engage in certain compulsive behaviors. The theory is that these medications may dampen reward signaling in the brain, reducing the intensity of cravings.

It’s important to emphasize that this research is still developing. We don’t yet have definitive answers about how effective GLP-1 medications are for addiction, who they might help most, or how they should be used in this context.

Biology Helps — But, It Doesn’t Replace Emotional Work

Even if medications can reduce the intensity of cravings, they don’t address everything involved in recovery. Emotional regulation, relationship patterns, stress tolerance, and long-standing coping habits still play a major role.

In therapy, we often work on:

• Identifying emotional triggers for use

• Building distress tolerance

• Understanding shame, resentment, and self-criticism

• Developing healthier relationship and communication patterns

Medication can sometimes lower the volume on cravings, but therapy helps people change how they relate to emotions and situations that previously led to using.

A Note on Medical Care

Decisions about medications — including GLP-1s, naltrexone, or others — should always be made in consultation with a qualified medical provider who understands your health history. As a therapist, my role is not to prescribe or recommend specific medications, but to support the emotional and behavioral side of recovery.

Where This Leaves Us

The exploration of GLP-1 medications in addiction treatment is an example of how our understanding of cravings continues to evolve. It highlights an important reality: recovery is influenced by both biology and psychology.

While research develops, therapy remains a key space for building emotional stability, resilience, and new patterns of coping; the skills that make long-term recovery more sustainable.

I provide private-pay psychotherapy for adults in Manhattan and Brooklyn, with a focus on emotional regulation, recovery-adjacent work, and relationship patterns. If you’re looking for support alongside medical or recovery-based care, you’re welcome to reach out through the Contact page.